Vitamin D in a northern country: who actually needs it

Vitamin D occupies a strange position. It is the one supplement a government actively tells the entire population to take, and simultaneously the one whose broader health claims have been most comprehensively deflated by large trials over the past decade.

Both of those things are true at once, and the distinction between them is what this article is about.

The geography problem

At UK latitudes, the sun sits too low between roughly October and March for the ultraviolet B wavelengths needed for vitamin D synthesis to reach the ground in useful quantity.

That is not a matter of cloud cover or how much time you spend outdoors. For about half the year, skin synthesis effectively stops regardless of behaviour. Someone who walks two hours a day in January produces essentially none.

Food does not fill the gap. Vitamin D occurs in meaningful amounts in only a handful of foods — oily fish, egg yolks, and fortified products — and typical diets deliver a fraction of the reference intake. This is unusual: for most nutrients, a varied diet gets you there. For this one, at this latitude, it does not.

Hence the recommendation. Since 2016, following advice from the Scientific Advisory Committee on Nutrition, UK guidance has been that everyone aged four and over should consider a daily 10 microgram (400 IU) supplement in autumn and winter. People with little sun exposure, or with darker skin — which reduces synthesis for a given amount of sunlight — are advised to take it year-round.

How many people are actually short

The surveys are consistent and unflattering. Roughly one in five UK adults is deficient. In working-age adults, around 19% of women and 16% of men fall below the threshold, and 13% of over-65s.

Adolescents come off worst: around 39% of girls and 15% of boys aged 11 to 18.

And most people are not following the advice. Surveys suggest around three-quarters of UK adults do not take the recommended supplement, with a majority believing they get enough from diet.

The argument about the number itself

Here is a detail that rarely appears in coverage, and it matters if you are deciding what to buy.

The UK defines deficiency as blood 25-hydroxyvitamin D below 25 nmol/L — the lowest threshold used by any national advisory body. The European Food Safety Authority and the US Institute of Medicine both use 50 nmol/L.

Because the recommended supplement dose is derived from the threshold, the UK’s 10 µg (400 IU) is correspondingly the lowest recommendation: 600 IU in the EU, 600–800 IU in the US depending on age.

A group of UK clinicians argued in Clinical Medicine that this is set too low, noted that they could not find published evidence supporting the 25 nmol/L threshold, and urged governments to recommend 20–25 µg (800–1,000 IU) daily. They also pointed out that UK blood levels typically fall by around 50% across the winter.

There is no consensus resolution to this. What it means practically is that 400 IU is a deficiency-avoidance floor rather than an optimisation target, and that 1,000 IU sits comfortably within what other national bodies consider reasonable, well below the UK’s own safe upper limit of 4,000 IU.

What vitamin D does — and what the trials found it does not do

This is where expectations need adjusting, because the last decade has been unkind to the more expansive claims.

Established: vitamin D is required for calcium absorption and bone mineralisation. Severe deficiency causes rickets in children and osteomalacia in adults. Correcting deficiency in deficient people works, and in older adults, adequate vitamin D with calcium has evidence for reducing fracture risk.

Not established, despite enormous effort: almost everything else.

Observational studies had linked low vitamin D to cardiovascular disease, cancer, autoimmune conditions, infections and mortality. The VITAL trial was built to test whether supplementation actually changes those outcomes. It randomised 25,871 initially healthy US adults to 2,000 IU of vitamin D3 or placebo, with a median treatment period of 5.3 years.

The result: vitamin D did not reduce major cardiovascular events, and did not reduce total invasive cancer incidence. Those were the two primary endpoints, and both were null. A related trial, ViDA, found no effect on all-cause mortality.

A secondary finding is worth reporting honestly alongside that: cancer mortality — as distinct from incidence — was reduced among participants followed for at least two years, a signal that updated meta-analyses have supported. Secondary endpoints in a trial with null primaries are hypothesis-generating, not conclusive.

The overall picture is that low vitamin D looks more like a marker of poor health than a cause of it. Sick people go outside less, and people who are outdoors more are different in many ways.

What to actually do

Take 10 µg (400 IU) daily from October to March. It is government advice, it costs a few pounds a year, and at this latitude the deficiency risk is real.

Consider 1,000 IU if you have darker skin, cover your skin, are housebound, are over 65, or rarely get outdoors — and consider taking it year-round. This sits within international norms and well under the safe upper limit.

Choose D3 over D2. It raises blood levels more effectively.

Get tested if there is a reason to. Persistent bone or muscle pain, a condition affecting fat absorption, or medications that interfere with vitamin D metabolism are reasons to have a level measured rather than guess. Routine testing of the general population is not recommended and mostly wastes money.

Do not exceed 4,000 IU daily without medical supervision. The UK safe upper limit exists because vitamin D is fat-soluble and accumulates. Very high doses cause hypercalcaemia, which damages kidneys.

The wider lesson

Vitamin D is the clearest case study in a pattern that recurs throughout longevity research, which is why it earns a place here beyond the practical advice.

An observational association — low levels track with worse outcomes across dozens of diseases — generated a decade of enthusiasm, a supplement industry, and confident claims about immunity, cancer and heart disease. Then a properly powered randomised trial with 25,871 participants tested the claims and found the headline benefits were not there.

The underlying nutrient still matters. Deficiency is real, common in this country, and worth correcting. But correcting a deficiency and enhancing health beyond sufficiency are different projects, and the evidence supports the first far better than the second.

That distinction is the single most useful thing to carry into any conversation about supplements.

---

This article is for general information and is not medical advice. If you have a condition affecting calcium metabolism, kidney disease, or take medication that interacts with vitamin D, speak to your GP before supplementing.

Sources

1. Scientific Advisory Committee on Nutrition. Vitamin D and health, 2016, and subsequent Public Health England advice. https://navigator.health.org.uk/theme/public-health-england-advice-vitamin-d
2. Griffin G, Hewison M, Hopkin J, et al. Preventing vitamin D deficiency during the COVID-19 pandemic: UK definitions of vitamin D sufficiency and recommended supplement dose are set too low. Clinical Medicine, 2021;21(1):e48–e51. https://pmc.ncbi.nlm.nih.gov/articles/PMC7850219
3. Manson JE, Cook NR, Lee I-M, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. New England Journal of Medicine, 2019;380:33–44.
4. VITAL study findings summary. https://www.vitalstudy.org/findings.html
5. British Heart Foundation. Vitamin D: deficiency, supplements, sunlight and diet. https://www.bhf.org.uk/informationsupport/heart-matters-magazine/nutrition/ask-the-expert/do-you-need-to-take-vitamin-d
6. Implementation strategies for improving vitamin D status and increasing vitamin D intake in the UK. Proceedings of the Nutrition Society. https://pmc.ncbi.nlm.nih.gov/articles/PMC8376911/